Recent developments of interest in cardiovascular medicine
A fourth type of carcinogen -- the solvent N,N-Dimethylformamide -- has been reported in valsartan (the third type was reported in March). While within the FDA's "safe" threshold, the citizen's petition by online pharmacy Valisure called for action because that limit is way out of line with other sartan contaminants. (Cardiovascular Business, in-PharmaTechnologist)